These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33095053)

  • 1. Engineered RNA-Interacting CRISPR Guide RNAs for Genetic Sensing and Diagnostics.
    Galizi R; Duncan JN; Rostain W; Quinn CM; Storch M; Kushwaha M; Jaramillo A
    CRISPR J; 2020 Oct; 3(5):398-408. PubMed ID: 33095053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
    Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR: development of a technology and its applications.
    Derry WB
    FEBS J; 2021 Jan; 288(2):358-359. PubMed ID: 33300275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9.
    Cui L; Vigouroux A; Rousset F; Varet H; Khanna V; Bikard D
    Nat Commun; 2018 May; 9(1):1912. PubMed ID: 29765036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Performance Allosteric Conditional Guide RNAs for Mammalian Cell-Selective Regulation of CRISPR/Cas.
    Hochrein LM; Li H; Pierce NA
    ACS Synth Biol; 2021 May; 10(5):964-971. PubMed ID: 33930275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PpCas9 from Pasteurella pneumotropica - a compact Type II-C Cas9 ortholog active in human cells.
    Fedorova I; Vasileva A; Selkova P; Abramova M; Arseniev A; Pobegalov G; Kazalov M; Musharova O; Goryanin I; Artamonova D; Zyubko T; Shmakov S; Artamonova T; Khodorkovskii M; Severinov K
    Nucleic Acids Res; 2020 Dec; 48(21):12297-12309. PubMed ID: 33152077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling and enhancing CRISPR systems.
    Shivram H; Cress BF; Knott GJ; Doudna JA
    Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs.
    Maxwell CS; Jacobsen T; Marshall R; Noireaux V; Beisel CL
    Methods; 2018 Jul; 143():48-57. PubMed ID: 29486239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR as a Diagnostic Tool.
    Kim S; Ji S; Koh HR
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas Systems in Streptococci.
    Gong T; Lu M; Zhou X; Zhang A; Tang B; Chen J; Jing M; Li Y
    Curr Issues Mol Biol; 2019; 32():1-38. PubMed ID: 31166168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving CRISPR Genome Editing by Engineering Guide RNAs.
    Moon SB; Kim DY; Ko JH; Kim JS; Kim YS
    Trends Biotechnol; 2019 Aug; 37(8):870-881. PubMed ID: 30846198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
    Liu L; Yin M; Wang M; Wang Y
    Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR RNA-guided autonomous delivery of Cas9.
    Wilkinson RA; Martin C; Nemudryi AA; Wiedenheft B
    Nat Struct Mol Biol; 2019 Jan; 26(1):14-24. PubMed ID: 30598555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR Tools for Engineering Prokaryotic Systems: Recent Advances and New Applications.
    Burbano DA; Kiattisewee C; Karanjia AV; Cardiff RAL; Faulkner ID; Sugianto W; Carothers JM
    Annu Rev Chem Biomol Eng; 2024 Jul; 15(1):389-430. PubMed ID: 38598861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas based antiviral strategies against HIV-1.
    Wang G; Zhao N; Berkhout B; Das AT
    Virus Res; 2018 Jan; 244():321-332. PubMed ID: 28760348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.